Heart Disease Trial, Recruiting NCT07660419 Sponsor: China National Center for Cardiovascular Diseases Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07660419
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with mild or moderate narrowing of one or more coronary arteries (the blood vessels supplying the heart), where a buildup of plaque is causing less than 70% blockage
  • People aged between 18 and 70 years
  • People who did not experience chest pain, abnormal heart rhythms, or concerning heart readings on a monitor during a fitness or exercise assessment
  • People whose blood test results show normal troponin levels (a protein that indicates heart muscle stress or damage)
  • People who have signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • People with severe narrowing (70% or more blockage) of the coronary arteries
  • People with serious heart or lung conditions, such as a recent heart attack, dangerous heart rhythm problems, fluid on the lungs, or severe narrowing of the aortic heart valve
  • People who experience chest pain or warning signs of reduced blood flow to the heart during light exercise or shortly after stopping exercise
  • People who have complex or dangerous heart rhythm problems at rest or during exercise
  • People whose blood pressure or heart rate responds abnormally during exercise testing (confirm with trial site)
  • People with severe psychological or mental health conditions
  • People whose heart pumping function is significantly reduced (the heart pumps less than 40% of its blood volume with each beat)
  • People whose blood test results show elevated troponin levels
  • People who are unable to complete an exercise fitness test due to nerve, muscle, or joint conditions
  • People with other serious health conditions (confirm with trial site for specific details)
  • People who decline to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-10-8839-6216

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
31 December 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

chang in non-calcified plaque volume

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov